Mimi Huizinga

Mimi Huizinga, an internist and epidemiologist, is dedicated to introducing healthcare innovations to patients and families while advocating for equitable access to advanced clinical care. With a background in data, digital technology, and analytics, Mimi is committed to improving healthcare outcomes and experiences.

Mimi Huizinga holds an MPH in Epidemiology, an MD in Medicine, and a BS in Biochemistry from reputable institutions such as Vanderbilt University School of Medicine, Mississippi State University, and the Alabama School of Mathematics and Science. Her diverse educational background has equipped her with a strong foundation for her career in the healthcare industry.

With an impressive professional trajectory, Mimi has held various key positions in distinguished organizations. She has served as the SVP and Head of US Oncology Medical at Novartis Oncology, showcasing her expertise in oncology and medical leadership. Additionally, her role as an Independent Director at HealthMyne, Inc. signifies her engagement in healthcare ventures beyond traditional medical settings.

Mimi's contributions extend to academia, having served as an Assistant Professor of Medicine at Johns Hopkins School of Medicine and as an Associate at McKinsey & Company, highlighting her commitment to education and consulting in the healthcare domain. Her roles at Novartis Oncology and Premier Inc. demonstrate her proficiency in strategic data management, digital healthcare solutions, and population health management.

Throughout her career, Mimi Huizinga has been actively involved in quality improvement initiatives, evident from her positions at Vanderbilt University Medical Center, LifePoint Hospitals, and the U.S. Department of Veterans Affairs. Her extensive experience as a Resident Physician in Internal Medicine at Vanderbilt University Medical Center has enriched her clinical acumen and patient care skills.